Middle-aged adults with higher vitamin D levels in their blood went on to have lower levels of tau protein in the brain roughly 16 years later, according to research published April 1, 2026, in Neurology Open Access, a journal of the American Academy of Neurology. Tau is one of the two hallmark proteins that accumulate in Alzheimer's disease, and its buildup tracks closely with cognitive decline.
The study followed 793 people with an average age of 39 who were free of dementia at the start. Researchers measured vitamin D in their blood at baseline, defining levels above 30 nanograms per milliliter as high and anything below that as low. An average of 16 years later, participants underwent brain scans that measured both tau and amyloid beta. The analysis accounted for age, sex and symptoms of depression, factors that could otherwise muddy the picture.
What makes this worth attention is timing. Most work on vitamin D and dementia looks at older adults, often after brain changes are already under way. Here the blood measurement came decades before the scans, which raises the possibility that vitamin D status in midlife matters for how much tau accumulates later. The researchers suggest low vitamin D could represent a modifiable risk factor, something that can be identified and addressed rather than simply endured.
The caveats are substantial and the authors say so plainly. This is an observational association, not proof that vitamin D lowers tau or reduces dementia risk. People with higher vitamin D levels may differ in other ways the study could not fully capture. The researchers themselves note the findings need testing in further studies before anyone can say whether raising vitamin D levels changes what happens in the brain.